Propanc Biopharma, Inc. (PPCB)
NASDAQ·Healthcare·Biotechnology
$0.10
+0.39%
Mkt Cap $2.68M
No analyst coverage available
We don't have analyst ratings or price target data for Propanc Biopharma, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.